Hepatitis B vaccination in Burkina Faso: prevalence of HBsAg carriage and immune response in children in the western region
Author(s) -
Armel Moumouni Sanou,
Abdoul Kader Ilboudo,
Zièmlé Clément Mèda,
Augustin Togozia,
Abou Coulibaly,
Assana Cissé,
Tani Sagna,
Dramane Kania,
Zékiba Tarnagda
Publication year - 2018
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.10433
Subject(s) - hbsag , medicine , vaccination , hepatitis b , carriage , hepatitis b virus , hepatitis b vaccine , titer , immunology , pediatrics , antibody , virus , pathology
Hepatitis B virus (HBV) infection remains a major health problem in Burkina Faso. To control and prevent HBV infection, Hepatitis B vaccine was introduced in the national expanded program in 2006. In this study, we evaluated the prevalence of HBsAg in children aged under 10 years after one decade of universal hepatitis B vaccination, and the immune response among these children.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom